![]() ![]() ![]() Your broker should mirror your investing goals, whether you like aggressive trading or a more conservative strategy. To purchase LinkDoc Technology Limited shares, you must first select a brokerage. To buy the LinkDoc Technology Limited IPO, you must first establish a brokerage account, then a trading account, deposit funds, and then start buying shares. Steps to Buy LinkDoc Technology Limited IPO LinkDoc Technology must be concerned about the United States enacting legislation that may result in international firms being delisted from American stock markets within three years if they fail to meet the country’s auditing criteria.LinkDoc Technology Ltd recorded a net loss of 135.4 million renminbi ($21.17 million) this year, up from 61.6 million renminbi the previous year.They have grown to become China’s largest patient-centric cancer continuous care platform.Ĭons of Owning LinkDoc Technology Limited Stock LinkDoc Technology Limited has treated over 3.5 million patients and provided longitudinal care for over 2.5 million patients since April 2015.LinkDoc Technology Limited has collaborated with over 500 first-tier hospitals in China, spanning over 30 provinces and regions.Pros of Owning LinkDoc Technology Limited Stock The following are some of the advantages and disadvantages of being a LinkDoc Technology Limited shareholder. Holding stock or shares in a firm has various advantages. The Good and the Bad of LinkDoc Technology Limited IPO Shan He and Tony Zhang founded LinkDoc in Beijing in 2014 to deliver healthcare services based on big data and artificial intelligence (AI) to give the most up-to-date cancer-focused care. LinkDoc Technology has created China’s top data-driven network infrastructure for precision medicine, which includes LinkCare, a digital ongoing care platform for patients with critical diseases LinkData, an Artificial intelligence curation framework for longitudinal medical data and LinkSolutions, which is a data-driven life sciences solution framework.Īs of March 31, 2021, they have developed a countrywide network of 34 patient care centers. Outlook for LinkDoc Technology Limited IPO They are creating LinkDoc solutions based on real-world big data in order to provide better cancer treatment to clinical doctors, the healthcare sector, and patients. They have created a proprietary machine learning and human language processing technique that allows us to organize millions of clinical EMR records into research-grade data. LinkDoc Technologies are a prominent oncology real-world big data business based in China, with the mission of bringing care data and care life together. When combined with financial security solutions, patients’ privacy and data may be protected without concern. No pricing terms were disclosed.LinkDoc provides a private hospital that is compliant with the HIPAA Act in the United States. Morgan Stanley, BofA Securities, and CICC are the joint bookrunners on the deal. It plans to list on the Nasdaq under the symbol LDOC. The Beijing, China-based company was founded in 2014 and booked $157 million in sales for the 12 months ended March 31, 2021. Since 2015, LinkDoc's platform has cumulatively cared for over 3.5 million patients and provided longitudinal care for over 2.5 million patients. The company's platform consist of LinkCare, a digital continuous care platform for patients with critical diseases, LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences platform that helps accelerate clinical research. LinkDoc Technology provides a data-driven and AI-enabled healthcare technology platform that structures cancer patient data to enable precision medicine and personalized care. LinkDoc Technology, a Chinese healthcare data company specializing in oncology patients, filed on Monday with the SEC to raise up to $100 million in an initial public offering.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |